Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,631,455
+$33,996 QoQ
Shares Held
10,410
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#483
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLDERNESS INVESTMENTS CO holds $26,485,557 across 10 Drug Manufacturers - General names. NVS ranks #8 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,463 | $5,904,229 | |
| 2 | MRK |
Merck & Co., Inc.
|
32,731 | $4,205,933 | |
| 3 | JNJ |
Johnson & Johnson
|
14,009 | $3,557,865 | |
| 4 | AMGN |
Amgen Inc
|
8,409 | $3,045,067 | |
| 5 | LLY |
ELI LILLY & Co
|
1,881 | $2,256,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,710 | $2,115,230 | |
| 7 | PFE |
Pfizer Inc
|
76,281 | $1,836,846 | |
| 8 | NVS |
Novartis AG
This page
|
10,410 | $1,631,455 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,631,455 | 10,410 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,597,459 | 10,458 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,441,844 | 10,458 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,354,599 | 10,563 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,394,882 | 11,527 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,268,865 | 11,382 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,070,993 | 11,006 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,220,822 | 10,614 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,046,288 | 9,828 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $885,563 | 9,155 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $937,001 | 9,280 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $945,260 | 9,280 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $938,967 | 9,305 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $827,540 | 8,995 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $800,785 | 8,827 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $665,239 | 8,752 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $726,281 | 8,592 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $949,542 | 10,821 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $909,250 | 10,395 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $817,145 | 9,992 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $881,013 | 9,656 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $711,706 | 8,326 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $784,430 | 8,307 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $733,681 | 8,437 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $736,887 | 8,437 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $435,418 | 5,281 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||